Multiple Biomarkers in Undiagnosed Pleural Effusion
Terminated
- Conditions
- Pleural EffusionPleural Effusion, Malignant
- Interventions
- Procedure: Procedure/Surgery
- First Posted Date
- 2006-04-20
- Last Posted Date
- 2011-11-08
- Lead Sponsor
- Fujirebio Diagnostics, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT00316134
- Locations
- 🇺🇸
Fujirebio Diagnostics, Inc, Malvern, Pennsylvania, United States
Risk of Ovarian Cancer in Patients With a Pelvic Mass
Completed
- Conditions
- Ovarian Cancer
- Interventions
- Device: Biomarker Assay (CA125 and HE4)
- First Posted Date
- 2006-04-19
- Last Posted Date
- 2011-11-08
- Lead Sponsor
- Fujirebio Diagnostics, Inc.
- Target Recruit Count
- 566
- Registration Number
- NCT00315692
- Locations
- 🇺🇸
Richard Moore, Providence, Rhode Island, United States
🇺🇸Fujirebio Diagnostics, Inc, Malvern, Pennsylvania, United States
Survivin Urine mRNA Assay Risk of Bladder Cancer Study
Completed
- Conditions
- Bladder Cancer
- First Posted Date
- 2006-04-19
- Last Posted Date
- 2008-03-14
- Lead Sponsor
- Fujirebio Diagnostics, Inc.
- Target Recruit Count
- 600
- Registration Number
- NCT00315653
- Locations
- 🇺🇸
Fujirebio Diagnostics, Inc, Malvern, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath